Sign In
Buy PEN
$319.37
+0.630 (+0.198%)
At Close: Jun 03, 2026
ITGR vs. PEN: Which Stock Is the Better Value Option?
12:47pm, Tuesday, 24'th Sep 2024
Investors with an interest in Medical - Instruments stocks have likely encountered both Integer (ITGR) and Penumbra (PEN). But which of these two companies is the best option for those looking for und
Why Penumbra Stock Zoomed Nearly 5% Higher Today
06:29pm, Wednesday, 18'th Sep 2024
A researcher initiated coverage of the medical device maker with a confident buy recommendation. He sees multiple positive factors that should propel its growth.
PEN Stock to Gain From CE Mark Approval for its CAVT Technologies
09:15am, Tuesday, 17'th Sep 2024
Penumbra receives the CE Mark approval for Lightning Flash 2.0 and Lightning Bolt 7 in Europe.
Latest computer assisted vacuum thrombectomy (CAVT) technologies combine superior catheter design with the latest dual clot detection computer algorithms designed to restore blood flow quickly Lightni
TFX or PEN: Which Is the Better Value Stock Right Now?
12:41pm, Wednesday, 04'th Sep 2024
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two stocks offers value investors a better bang for their buck right
Why Is Penumbra (PEN) Up 20% Since Last Earnings Report?
12:37pm, Thursday, 29'th Aug 2024
Penumbra (PEN) reported earnings 30 days ago. What's next for the stock?
Penumbra, Inc. to Present at the Baird Global Healthcare Conference
04:30pm, Tuesday, 27'th Aug 2024
ALAMEDA, Calif. , Aug. 27, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Baird Global Healthcare Conference on Tuesday, Septem
Penumbra, Inc. to Present at the Wells Fargo Healthcare Conference
04:30pm, Wednesday, 21'st Aug 2024
ALAMEDA, Calif. , Aug. 21, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Wells Fargo Healthcare Conference on Wednesday, Septe
Penumbra: Growth In Its Thrombectomy Portfolio Should Lead To Strong Earnings
09:28pm, Monday, 19'th Aug 2024
Penumbra is continuing to take share with its new CAVT devices against its closest competition in the VTE space. PEN reduced guidance after Q2 earnings, but the market took it in stride, with difficul
Penumbra, Inc. Announces $200 Million Share Repurchase Authorization
07:00am, Tuesday, 13'th Aug 2024
To Include $100 Million Accelerated Share Repurchase ALAMEDA, Calif. , Aug. 13, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today announced that its Boar
Penumbra, Inc. to Present at the Canaccord Genuity Growth Conference
04:30pm, Friday, 02'nd Aug 2024
ALAMEDA, Calif. , Aug. 2, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord Genuity Growth Conference on Tuesday, August
Penumbra (PEN) Tops on Q2 Earnings, Lowers Sales View
11:05am, Wednesday, 31'st Jul 2024
Penumbra's (PEN) Thrombectomy product category shows encouraging growth trends, reflecting strong momentum in CAVT products.
Penumbra (PEN) Reports Q2 Earnings: What Key Metrics Have to Say
08:06pm, Tuesday, 30'th Jul 2024
While the top- and bottom-line numbers for Penumbra (PEN) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to
Penumbra, Inc. (PEN) Q2 2024 Earnings Call Transcript
07:25pm, Tuesday, 30'th Jul 2024
Penumbra, Inc. (NYSE:PEN ) Q2 2024 Earnings Conference Call July 30, 2024 4:30 PM ET Company Participants Cecilia Furlong - Director of Business Development and Investor Relations Adam Elsesser - Chai
Penumbra (PEN) Q2 Earnings and Revenues Beat Estimates
06:31pm, Tuesday, 30'th Jul 2024
Penumbra (PEN) came out with quarterly earnings of $0.64 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.43 per share a year ago.
